What is Zacks Research’s Estimate for CME Group Q4 Earnings?

CME Group Inc. (NASDAQ:CME) – Equities researchers at Zacks Research upped their Q4 2025 earnings per share (EPS) estimates for shares of CME Group in a research note issued to investors on Thursday, April 10th. Zacks Research analyst T. De now forecasts that the financial services provider will post earnings of $2.63 per share for the quarter, up from their previous forecast of $2.53. The consensus estimate for CME Group’s current full-year earnings is $10.49 per share. Zacks Research also issued estimates for CME Group’s Q4 2026 earnings at $2.87 EPS.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, topping analysts’ consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%.

CME has been the topic of a number of other reports. Raymond James upgraded CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price target on the stock in a research note on Monday, March 10th. Keefe, Bruyette & Woods increased their price objective on CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a research report on Friday, February 14th. Morgan Stanley raised shares of CME Group from an “equal weight” rating to an “overweight” rating and set a $301.00 price objective on the stock in a research note on Tuesday, April 8th. Citigroup downgraded shares of CME Group from a “buy” rating to a “neutral” rating and lowered their target price for the company from $255.00 to $250.00 in a report on Monday, January 6th. Finally, Erste Group Bank upgraded shares of CME Group to a “strong-buy” rating in a research report on Monday, March 17th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $247.47.

CME Group Price Performance

Shares of NASDAQ CME opened at $262.87 on Monday. The stock’s 50-day moving average is $256.03 and its two-hundred day moving average is $239.72. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The company has a market cap of $94.73 billion, a price-to-earnings ratio of 27.18, a price-to-earnings-growth ratio of 6.76 and a beta of 0.43. CME Group has a 1-year low of $190.70 and a 1-year high of $273.42.

Institutional Investors Weigh In On CME Group

Large investors have recently added to or reduced their stakes in the stock. SJS Investment Consulting Inc. grew its position in CME Group by 570.6% in the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 97 shares during the last quarter. New Age Alpha Advisors LLC raised its holdings in shares of CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock worth $30,000 after buying an additional 43 shares in the last quarter. Financial Life Planners bought a new position in shares of CME Group during the 4th quarter worth approximately $32,000. Knuff & Co LLC acquired a new position in CME Group during the fourth quarter worth $33,000. Finally, Fortitude Family Office LLC lifted its holdings in shares of CME Group by 120.3% during the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after acquiring an additional 83 shares during the period. Institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling

In other CME Group news, Director Howard J. Siegel sold 10,000 shares of the company’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the completion of the sale, the director now directly owns 21,873 shares of the company’s stock, valued at approximately $5,686,980. This represents a 31.37 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Hilda Harris Piell sold 3,984 shares of the stock in a transaction dated Thursday, February 27th. The stock was sold at an average price of $250.47, for a total value of $997,872.48. Following the completion of the sale, the insider now directly owns 27,046 shares of the company’s stock, valued at approximately $6,774,211.62. This represents a 12.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 27,076 shares of company stock valued at $6,871,496. Insiders own 0.30% of the company’s stock.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th were issued a $1.25 dividend. The ex-dividend date of this dividend was Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a yield of 1.90%. This is a boost from CME Group’s previous quarterly dividend of $1.15. CME Group’s dividend payout ratio (DPR) is currently 51.71%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.